Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment

Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment Who Are Undergoing Ambulatory Surgery- a Case Series

In this case series study, the investigators are testing the hypothesis that sublingual sufentanil (Dsuvia) will improve postoperative pain management in the Post Anesthesia Care Unit (PACU) in ambulatory surgery patients taking Suboxone.

Inclusion Criteria:

• Age range 18-100 years
• Currently taking Suboxone
• ASA (American Society of Anesthesiology) physical score 1-3
• Able to provide a signed informed consent
• General anesthesia (either endotracheal intubation or laryngeal mask airway) or MAC (monitored anesthesia care) without the use of regional anesthesia

Exclusion Criteria:

• Known allergic reactions to Dsuvia and its excipients
• Severe respiratory illness including exacerbation of asthma attack
• Significant intraoperative hemodynamic instability
• Use of Regional anesthesia techniques